Bioceutiq

Bioceutiq is a specialty pharmaceutical company that operates as a division of Macleods Pharmaceuticals, focusing on high-growth therapeutic segments including oncology, nephrology, and critical care. The company is dedicated to providing complex and specialized medicines, including branded generics and biosimilars, to improve patient access to advanced treatments. Bioceutiq utilizes sophisticated drug delivery technologies, such as liposomal and nanoparticle formulations, to develop its product portfolio. With a strong emphasis on the Indian market and a growing international presence, the company provides a wide range of therapies for cancer, chronic kidney disease, and life-threatening infections. Bioceutiq benefits from the robust manufacturing and R&D infrastructure of Macleods Pharmaceuticals, ensuring high standards of quality and compliance.